HEADER TRANSFERASE/TRANSFERASE INHIBITOR 27-AUG-13 4MF0 TITLE ITK KINASE DOMAIN IN COMPLEX WITH BENZOTHIAZOLE INHIBITOR COMPOUND 12A TITLE 2 (1S,2S)-2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(PYRIDIN-3-YL)-1,3- TITLE 3 BENZOTHIAZOL-2-YL]CYCLOPROPANECARBOXAMIDE (12A) COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ITK/TSK; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 357-620; COMPND 5 SYNONYM: INTERLEUKIN-2-INDUCIBLE T-CELL KINASE, IL-2-INDUCIBLE T-CELL COMPND 6 KINASE, KINASE EMT, T-CELL-SPECIFIC KINASE, TYROSINE-PROTEIN KINASE COMPND 7 LYK; COMPND 8 EC: 2.7.10.2; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EMT, ITK, LYK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PROTEIN KINASE, PHOSPHOTRANSFER CATALYST, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.EIGENBROT,S.SHIA REVDAT 3 28-FEB-24 4MF0 1 REMARK SEQADV REVDAT 2 20-NOV-13 4MF0 1 JRNL REVDAT 1 13-NOV-13 4MF0 0 JRNL AUTH C.H.MACKINNON,K.LAU,J.D.BURCH,Y.CHEN,J.DINES,X.DING, JRNL AUTH 2 C.EIGENBROT,A.HEIFETZ,A.JAOCHICO,A.JOHNSON,J.KRAEMER, JRNL AUTH 3 S.KRUGER,T.M.KRULLE,M.LIIMATTA,J.LY,R.MAGHAMES, JRNL AUTH 4 C.A.MONTALBETTI,D.F.ORTWINE,Y.PEREZ-FUERTES,S.SHIA, JRNL AUTH 5 D.B.STEIN,G.TRANI,D.G.VAIDYA,X.WANG,S.M.BROMIDGE,L.C.WU, JRNL AUTH 6 Z.PEI JRNL TITL STRUCTURE-BASED DESIGN AND SYNTHESIS OF POTENT BENZOTHIAZOLE JRNL TITL 2 INHIBITORS OF INTERLEUKIN-2 INDUCIBLE T CELL KINASE (ITK). JRNL REF BIOORG.MED.CHEM.LETT. V. 23 6331 2013 JRNL REFN ISSN 0960-894X JRNL PMID 24138940 JRNL DOI 10.1016/J.BMCL.2013.09.069 REMARK 2 REMARK 2 RESOLUTION. 2.67 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.67 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.16 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 16341 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 829 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.67 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.85 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.66 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2955 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2475 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2790 REMARK 3 BIN R VALUE (WORKING SET) : 0.2460 REMARK 3 BIN FREE R VALUE : 0.2737 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.58 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 165 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3817 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 25 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 65.42 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.62060 REMARK 3 B22 (A**2) : -11.08220 REMARK 3 B33 (A**2) : 14.70280 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -5.91860 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.371 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 1.309 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.906 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.827 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3969 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5361 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1375 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 96 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 565 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3969 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 485 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4473 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.46 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.29 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MF0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1000081827. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-AUG-10 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : DIAMOND [111] REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16341 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.670 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08800 REMARK 200 FOR THE DATA SET : 14.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: POTASSIUM THIOCYANATE, PEG3350, PH REMARK 280 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 77.74400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 355 REMARK 465 SER A 356 REMARK 465 GLY A 372 REMARK 465 GLN A 373 REMARK 465 PHE A 374 REMARK 465 ARG A 394 REMARK 465 GLU A 395 REMARK 465 GLY A 396 REMARK 465 ALA A 397 REMARK 465 ARG A 505 REMARK 465 PHE A 506 REMARK 465 VAL A 507 REMARK 465 LEU A 508 REMARK 465 ASP A 509 REMARK 465 ASP A 510 REMARK 465 GLN A 511 REMARK 465 GLU A 512 REMARK 465 THR A 513 REMARK 465 SER A 514 REMARK 465 SER A 515 REMARK 465 THR A 516 REMARK 465 GLY A 517 REMARK 465 THR A 518 REMARK 465 LYS A 519 REMARK 465 PHE A 520 REMARK 465 LEU A 620 REMARK 465 GLY B 355 REMARK 465 SER B 356 REMARK 465 GLY B 372 REMARK 465 GLN B 373 REMARK 465 PHE B 374 REMARK 465 ARG B 394 REMARK 465 GLU B 395 REMARK 465 GLY B 396 REMARK 465 ALA B 397 REMARK 465 GLY B 502 REMARK 465 MET B 503 REMARK 465 THR B 504 REMARK 465 ARG B 505 REMARK 465 PHE B 506 REMARK 465 VAL B 507 REMARK 465 LEU B 508 REMARK 465 ASP B 509 REMARK 465 ASP B 510 REMARK 465 GLN B 511 REMARK 465 GLU B 512 REMARK 465 THR B 513 REMARK 465 SER B 514 REMARK 465 SER B 515 REMARK 465 THR B 516 REMARK 465 GLY B 517 REMARK 465 THR B 518 REMARK 465 LYS B 519 REMARK 465 PHE B 520 REMARK 465 LEU B 620 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 360 -75.47 -89.95 REMARK 500 SER A 361 57.51 -164.22 REMARK 500 VAL A 366 -61.09 -125.30 REMARK 500 GLU A 427 45.85 -74.72 REMARK 500 GLN A 428 -152.57 46.83 REMARK 500 ALA A 429 -148.53 60.01 REMARK 500 ARG A 481 -20.92 74.19 REMARK 500 ASP A 482 49.36 -141.94 REMARK 500 ASN A 493 70.31 41.01 REMARK 500 GLN A 494 19.85 49.27 REMARK 500 SER A 531 -62.14 -93.12 REMARK 500 ASN A 561 63.78 -117.46 REMARK 500 SER A 618 -108.60 -120.55 REMARK 500 PRO B 360 -71.92 -78.97 REMARK 500 SER B 361 74.97 177.99 REMARK 500 VAL B 366 -63.69 -125.53 REMARK 500 ILE B 369 -40.23 -140.59 REMARK 500 SER B 399 78.90 48.20 REMARK 500 GLU B 427 47.88 -72.63 REMARK 500 GLN B 428 -161.26 48.68 REMARK 500 ALA B 429 -164.30 61.62 REMARK 500 ARG B 481 -24.32 79.95 REMARK 500 ASP B 482 72.81 -150.38 REMARK 500 ASP B 500 76.10 59.06 REMARK 500 GLU B 560 -67.82 -29.81 REMARK 500 ASN B 561 71.82 -117.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 29Z A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 29Z B 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4MF1 RELATED DB: PDB DBREF 4MF0 A 357 620 UNP Q08881 ITK_HUMAN 357 620 DBREF 4MF0 B 357 620 UNP Q08881 ITK_HUMAN 357 620 SEQADV 4MF0 GLY A 355 UNP Q08881 EXPRESSION TAG SEQADV 4MF0 SER A 356 UNP Q08881 EXPRESSION TAG SEQADV 4MF0 GLU A 512 UNP Q08881 TYR 512 ENGINEERED MUTATION SEQADV 4MF0 GLY B 355 UNP Q08881 EXPRESSION TAG SEQADV 4MF0 SER B 356 UNP Q08881 EXPRESSION TAG SEQADV 4MF0 GLU B 512 UNP Q08881 TYR 512 ENGINEERED MUTATION SEQRES 1 A 266 GLY SER VAL ILE ASP PRO SER GLU LEU THR PHE VAL GLN SEQRES 2 A 266 GLU ILE GLY SER GLY GLN PHE GLY LEU VAL HIS LEU GLY SEQRES 3 A 266 TYR TRP LEU ASN LYS ASP LYS VAL ALA ILE LYS THR ILE SEQRES 4 A 266 ARG GLU GLY ALA MET SER GLU GLU ASP PHE ILE GLU GLU SEQRES 5 A 266 ALA GLU VAL MET MET LYS LEU SER HIS PRO LYS LEU VAL SEQRES 6 A 266 GLN LEU TYR GLY VAL CYS LEU GLU GLN ALA PRO ILE CYS SEQRES 7 A 266 LEU VAL PHE GLU PHE MET GLU HIS GLY CYS LEU SER ASP SEQRES 8 A 266 TYR LEU ARG THR GLN ARG GLY LEU PHE ALA ALA GLU THR SEQRES 9 A 266 LEU LEU GLY MET CYS LEU ASP VAL CYS GLU GLY MET ALA SEQRES 10 A 266 TYR LEU GLU GLU ALA CYS VAL ILE HIS ARG ASP LEU ALA SEQRES 11 A 266 ALA ARG ASN CYS LEU VAL GLY GLU ASN GLN VAL ILE LYS SEQRES 12 A 266 VAL SER ASP PHE GLY MET THR ARG PHE VAL LEU ASP ASP SEQRES 13 A 266 GLN GLU THR SER SER THR GLY THR LYS PHE PRO VAL LYS SEQRES 14 A 266 TRP ALA SER PRO GLU VAL PHE SER PHE SER ARG TYR SER SEQRES 15 A 266 SER LYS SER ASP VAL TRP SER PHE GLY VAL LEU MET TRP SEQRES 16 A 266 GLU VAL PHE SER GLU GLY LYS ILE PRO TYR GLU ASN ARG SEQRES 17 A 266 SER ASN SER GLU VAL VAL GLU ASP ILE SER THR GLY PHE SEQRES 18 A 266 ARG LEU TYR LYS PRO ARG LEU ALA SER THR HIS VAL TYR SEQRES 19 A 266 GLN ILE MET ASN HIS CYS TRP LYS GLU ARG PRO GLU ASP SEQRES 20 A 266 ARG PRO ALA PHE SER ARG LEU LEU ARG GLN LEU ALA GLU SEQRES 21 A 266 ILE ALA GLU SER GLY LEU SEQRES 1 B 266 GLY SER VAL ILE ASP PRO SER GLU LEU THR PHE VAL GLN SEQRES 2 B 266 GLU ILE GLY SER GLY GLN PHE GLY LEU VAL HIS LEU GLY SEQRES 3 B 266 TYR TRP LEU ASN LYS ASP LYS VAL ALA ILE LYS THR ILE SEQRES 4 B 266 ARG GLU GLY ALA MET SER GLU GLU ASP PHE ILE GLU GLU SEQRES 5 B 266 ALA GLU VAL MET MET LYS LEU SER HIS PRO LYS LEU VAL SEQRES 6 B 266 GLN LEU TYR GLY VAL CYS LEU GLU GLN ALA PRO ILE CYS SEQRES 7 B 266 LEU VAL PHE GLU PHE MET GLU HIS GLY CYS LEU SER ASP SEQRES 8 B 266 TYR LEU ARG THR GLN ARG GLY LEU PHE ALA ALA GLU THR SEQRES 9 B 266 LEU LEU GLY MET CYS LEU ASP VAL CYS GLU GLY MET ALA SEQRES 10 B 266 TYR LEU GLU GLU ALA CYS VAL ILE HIS ARG ASP LEU ALA SEQRES 11 B 266 ALA ARG ASN CYS LEU VAL GLY GLU ASN GLN VAL ILE LYS SEQRES 12 B 266 VAL SER ASP PHE GLY MET THR ARG PHE VAL LEU ASP ASP SEQRES 13 B 266 GLN GLU THR SER SER THR GLY THR LYS PHE PRO VAL LYS SEQRES 14 B 266 TRP ALA SER PRO GLU VAL PHE SER PHE SER ARG TYR SER SEQRES 15 B 266 SER LYS SER ASP VAL TRP SER PHE GLY VAL LEU MET TRP SEQRES 16 B 266 GLU VAL PHE SER GLU GLY LYS ILE PRO TYR GLU ASN ARG SEQRES 17 B 266 SER ASN SER GLU VAL VAL GLU ASP ILE SER THR GLY PHE SEQRES 18 B 266 ARG LEU TYR LYS PRO ARG LEU ALA SER THR HIS VAL TYR SEQRES 19 B 266 GLN ILE MET ASN HIS CYS TRP LYS GLU ARG PRO GLU ASP SEQRES 20 B 266 ARG PRO ALA PHE SER ARG LEU LEU ARG GLN LEU ALA GLU SEQRES 21 B 266 ILE ALA GLU SER GLY LEU HET 29Z A 701 31 HET 29Z B 701 31 HETNAM 29Z (1S,2S)-2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6- HETNAM 2 29Z (PYRIDIN-3-YL)-1,3-BENZOTHIAZOL-2- HETNAM 3 29Z YL]CYCLOPROPANECARBOXAMIDE FORMUL 3 29Z 2(C25 H24 N4 O S) FORMUL 5 HOH *25(H2 O) HELIX 1 1 SER A 399 LEU A 413 1 15 HELIX 2 2 LEU A 443 THR A 449 1 7 HELIX 3 3 ALA A 455 ALA A 476 1 22 HELIX 4 4 GLU A 492 GLN A 494 5 3 HELIX 5 5 SER A 526 PHE A 532 1 7 HELIX 6 6 SER A 536 SER A 553 1 18 HELIX 7 7 SER A 563 GLY A 574 1 12 HELIX 8 8 SER A 584 TRP A 595 1 12 HELIX 9 9 ARG A 598 ARG A 602 5 5 HELIX 10 10 ALA A 604 SER A 618 1 15 HELIX 11 11 SER B 399 LYS B 412 1 14 HELIX 12 12 CYS B 442 GLN B 450 1 9 HELIX 13 13 ALA B 455 ALA B 476 1 22 HELIX 14 14 ALA B 484 ARG B 486 5 3 HELIX 15 15 GLU B 492 GLN B 494 5 3 HELIX 16 16 PRO B 521 ALA B 525 5 5 HELIX 17 17 SER B 526 SER B 533 1 8 HELIX 18 18 SER B 536 SER B 553 1 18 HELIX 19 19 SER B 563 THR B 573 1 11 HELIX 20 20 SER B 584 TRP B 595 1 12 HELIX 21 21 ARG B 598 ARG B 602 5 5 HELIX 22 22 ALA B 604 GLY B 619 1 16 SHEET 1 A 4 LEU A 363 GLU A 368 0 SHEET 2 A 4 VAL A 377 ILE A 393 -1 O LEU A 379 N GLN A 367 SHEET 3 A 4 VAL B 377 ILE B 393 -1 O GLY B 380 N VAL A 388 SHEET 4 A 4 LEU B 363 GLU B 368 -1 N GLN B 367 O LEU B 379 SHEET 1 B 7 ILE B 358 ASP B 359 0 SHEET 2 B 7 LEU A 421 CYS A 425 1 N VAL A 424 O ASP B 359 SHEET 3 B 7 ILE A 431 GLU A 436 -1 O CYS A 432 N CYS A 425 SHEET 4 B 7 VAL A 377 ILE A 393 -1 N ILE A 393 O ILE A 431 SHEET 5 B 7 VAL B 377 ILE B 393 -1 O GLY B 380 N VAL A 388 SHEET 6 B 7 ILE B 431 GLU B 436 -1 O PHE B 435 N ALA B 389 SHEET 7 B 7 LEU B 421 CYS B 425 -1 N GLY B 423 O VAL B 434 SHEET 1 C 3 GLY A 441 CYS A 442 0 SHEET 2 C 3 LEU A 489 VAL A 490 -1 O VAL A 490 N GLY A 441 SHEET 3 C 3 ILE A 496 LYS A 497 -1 O LYS A 497 N LEU A 489 SHEET 1 D 2 CYS B 488 VAL B 490 0 SHEET 2 D 2 ILE B 496 VAL B 498 -1 O LYS B 497 N LEU B 489 SITE 1 AC1 12 LYS A 387 ALA A 389 LYS A 391 GLU A 401 SITE 2 AC1 12 PHE A 435 GLU A 436 PHE A 437 MET A 438 SITE 3 AC1 12 GLU A 439 GLY A 441 LEU A 489 SER A 499 SITE 1 AC2 13 GLN A 367 LEU A 379 LYS B 387 ALA B 389 SITE 2 AC2 13 LYS B 391 PHE B 435 GLU B 436 PHE B 437 SITE 3 AC2 13 MET B 438 GLU B 439 GLY B 441 LEU B 489 SITE 4 AC2 13 SER B 499 CRYST1 40.145 155.488 47.257 90.00 93.74 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024910 0.000000 0.001628 0.00000 SCALE2 0.000000 0.006431 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021206 0.00000